Skip to main content

Research News

Crack GPAT — Prepare for GPAT Online 
  • Tulane researchers use AI to improve diagnosis of drug-resistant infections

    Drug-resistant infections especially from deadly bacteria like tuberculosis and staph are a growing global health crisis. These infections are harder to treat, often require more expensive or toxic medications and are responsible for longer hospital stays and higher mortality rates.
  • A rice sized pacemaker that heals and dissolves, need no surgery

    Northwestern University engineers have developed a pacemaker so tiny that it can fit inside the tip of a syringe — and be non-invasively injected into the body.

    Although it can work with hearts of all sizes, the pacemaker is particularly well-suited to the tiny, fragile hearts of newborn babies with congenital heart defects.

  • Organogold (III) complex accumulates in mitochondria of lung cancer cells

    Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug cisplatin. Recently, the search for alternatives with improved activity has begun to focus on gold. In the journal Angewandte Chemie, a French research team has now published the first study about the speciation and distribution of an organogold(III) complex in cancer cells and reveals how specially designed “organogold” complexes might open exciting avenues for fighting cancer. 

  • First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

    The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ethnic backgrounds. The new guideline, based on systematic literature reviews and published in the International Journal of Neonatal Screening, reflects rigorous scientific investigation and perspectives from parents, CF specialists, public health representatives, primary care providers and genetic counselors.

  • How healthy microbes in infancy reduce diabetes risk
    Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice suggests. The study, published this month in the journal Science, also pinpoints specific microorganisms that may help those critical cells proliferate in early life.
  • mRNA-based COVID-19 vaccines train the ‘long-term memory’ of the immune system
    Researchers at the University of Cologne have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential future infections / publication in Molecular Systems Biology
  • Growing Body of Evidence Links HPV with Heart Disease
    In addition to causing several types of cancer, human papillomavirus appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being presented at the American College of Cardiology's Annual Scientific Session.
  • New Evidence Links Microplastics with Chronic Disease

    Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can be inadvertently consumed or inhaled, is associated with a heightened prevalence of chronic noncommunicable diseases, according to new research being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

  • Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
    Innovent Biologics, Inc , a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed with IBI354
  • Treating chronic inflammatory diseases with JAK inhibitors
    Janus kinase inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohns disease or ulcerative colitis. Since their approval, the indications for these medical drugs have steadily increased, but recently safety concerns have also been raised.
Subscribe to Research News